Patient Selection | Orasi Medical, Inc.

Products and Services >> Patient Selection

Tools for Selecting the Right Subjects

Drug failures often are caused by inadequate or poor study population selection. Defining and then recruiting the right study group requires objective tools to characterize disease states and stages.

Orasi Index™ enhances CNS trial success by improving patient selection.

Measuring Alzheimer’s disease severity (n=317) by the Orasi Index

Real-time measure of brain function

Click on the image above to learn more--

The Orasi Index accurately measures neurological drug effect throughout the drug development process to accelerate and improve clinical outcomes.

Register to receive product updates:
Keep up-to-date about our rapidly growing database of drug and disease signatures as well as other relevant Orasi Medical developments.